491 related articles for article (PubMed ID: 33503974)
1. Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway.
Vallée A; Vallée JN; Lecarpentier Y
Cells; 2021 Jan; 10(2):. PubMed ID: 33503974
[TBL] [Abstract][Full Text] [Related]
2. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.
Vallée A; Vallée JN; Lecarpentier Y
Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261
[TBL] [Abstract][Full Text] [Related]
3. Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT/β pathway.
Vallée A; Vallée JN; Lecarpentier Y
Transl Psychiatry; 2021 Apr; 11(1):204. PubMed ID: 33828076
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma.
Vallée A; Lecarpentier Y; Vallée JN
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917605
[TBL] [Abstract][Full Text] [Related]
5. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
6. Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma.
Vallée A; Vallée JN; Lecarpentier Y
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33925885
[TBL] [Abstract][Full Text] [Related]
7. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.
Vallée A; Lecarpentier Y; Vallée JN
Mol Psychiatry; 2022 Jan; 27(1):230-248. PubMed ID: 33837269
[TBL] [Abstract][Full Text] [Related]
8. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Guttuso T
Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
[TBL] [Abstract][Full Text] [Related]
9. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Yue Y; Qiao B; Jiang X
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380
[TBL] [Abstract][Full Text] [Related]
10. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
12. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
[TBL] [Abstract][Full Text] [Related]
13. Effect of Roucongrong (Herba Cistanches Deserticolae) decoction on the substantia nigra through Wnt/β-catenin signaling pathway in rats with Parkinson's disease induced by 6-hydroxydopamine hydrochloride.
Xu Q; Qin W; Wu FZ; Lin Y; Hong LT; Chen D; Hu XF; Cai J
J Tradit Chin Med; 2021 Oct; 41(5):762-770. PubMed ID: 34708635
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease.
Huang YL; Zhang JN; Hou TZ; Gu L; Yang HM; Zhang H
Neurochem Int; 2022 Oct; 159():105389. PubMed ID: 35809720
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Curcumin Against Oxidative Stress-Induced Injury in Rats with Parkinson's Disease Through the Wnt/ β-Catenin Signaling Pathway.
Wang YL; Ju B; Zhang YZ; Yin HL; Liu YJ; Wang SS; Zeng ZL; Yang XP; Wang HT; Li JF
Cell Physiol Biochem; 2017; 43(6):2226-2241. PubMed ID: 29069652
[TBL] [Abstract][Full Text] [Related]
16. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
[TBL] [Abstract][Full Text] [Related]
17. Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway.
Ji M; Niu SQ; Mi HY; Jiang P; Li Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14358. PubMed ID: 37749299
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
20. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.
Marchetti B
Redox Biol; 2020 Sep; 36():101664. PubMed ID: 32863224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
